Log in
Enquire now
‌

US Patent 9458158 Bicyclic heterocycle compounds and their uses in therapy

Patent 9458158 was granted and assigned to Astex Therapeutics Limited on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Astex Therapeutics Limited
0
Current Assignee
‌
Astex Therapeutics Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
94581580
Patent Inventor Names
Gianni Chessari0
Steven Howard0
Alison Jo-Anne Woolford0
David Charles Rees0
Ildiko Maria Buck0
Date of Patent
October 4, 2016
0
Patent Application Number
148363260
Date Filed
August 26, 2015
0
Patent Citations Received
‌
US Patent 11866428 Bicyclic heterocycle compounds and their uses in therapy
0
Patent Primary Examiner
‌
Kahsay Habte
0
Patent abstract

The invention relates to bicyclic heterocycle compounds of formula (I): or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically acceptable salts or the solvates thereof; wherein R1, R2, R3, A, W, U and V are as defined herein; to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9458158 Bicyclic heterocycle compounds and their uses in therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.